Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00803634 · ClinicalTrials.gov registry record · Phase 3
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)
A Phase 3 study, sponsored by The Medicines Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 117
- Enrollment target
NCT00803634 is a Phase 3 study that has completed, run by The Medicines Company. The registered enrollment target is 117 participants.
The verdict
NCT00803634, a Phase 3 study, has completed, sponsored by The Medicines Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 117 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the efficacy and safety of intravenous (IV) clevidipine as compared with standard of care IV antihypertensive agents for blood pressure (BP) lowering in patients with acute heart failure and elevated BP.
Interventions
- DRUG Clevidipine
- DRUG Standard of Care IV antihypertensive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00803634
The ClinicalTrials.gov registry entry for NCT00803634 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Medicines Company, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clevidipine is the first listed.
NCT00803634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00803634 about?
NCT00803634 is a clinical study titled "Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)". The purpose of this study was to evaluate the efficacy and safety of intravenous (IV) clevidipine as compared with standard of care IV antihypertensive agents for blood pressure (BP) lowering in patients with acute heart failure and elevated BP.
What is the current status of trial NCT00803634?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 117 participants. The study started on 2008-12. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00803634?
The interventions under investigation include: Clevidipine (DRUG), Standard of Care IV antihypertensive (DRUG).
Who is sponsoring clinical trial NCT00803634?
This trial is sponsored by The Medicines Company, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.